ViroGates A/S (VIRO.CO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jakob Knudsen | Chief Executive Officer | 1.61M | -- | 1968 |
| Dr. Jesper Eugen-Olsen | Co-Founder & Chief Scientific Officer | -- | -- | 1963 |
| Ms. Josephine Baum Jorgensen | Chief Financial Officer | -- | -- | 1991 |
| Ms. May Britt Dyvelkov | Vice President of Accounting | -- | -- | 1960 |
| Mr. Thomas Krarup | Vice President of Global Sales & Marketing | -- | -- | 1963 |
ViroGates A/S
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 7
Description
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company's product includes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; and suPARnostic Quick Triage kit for use in the point of care situation for early warning and patient triaging that allows clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression, and outcome. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available